1. Home
  2. MRKR vs NA Comparison

MRKR vs NA Comparison

Compare MRKR & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • NA
  • Stock Information
  • Founded
  • MRKR N/A
  • NA 2019
  • Country
  • MRKR United States
  • NA China
  • Employees
  • MRKR N/A
  • NA N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • NA Semiconductors
  • Sector
  • MRKR Health Care
  • NA Technology
  • Exchange
  • MRKR Nasdaq
  • NA Nasdaq
  • Market Cap
  • MRKR 35.8M
  • NA 32.3M
  • IPO Year
  • MRKR N/A
  • NA 2022
  • Fundamental
  • Price
  • MRKR $3.50
  • NA $4.50
  • Analyst Decision
  • MRKR Strong Buy
  • NA
  • Analyst Count
  • MRKR 1
  • NA 0
  • Target Price
  • MRKR $19.00
  • NA N/A
  • AVG Volume (30 Days)
  • MRKR 34.9K
  • NA 159.4K
  • Earning Date
  • MRKR 11-22-2024
  • NA 09-18-2024
  • Dividend Yield
  • MRKR N/A
  • NA N/A
  • EPS Growth
  • MRKR N/A
  • NA N/A
  • EPS
  • MRKR N/A
  • NA N/A
  • Revenue
  • MRKR $3,727,435.00
  • NA $6,991,446.00
  • Revenue This Year
  • MRKR $35.94
  • NA N/A
  • Revenue Next Year
  • MRKR N/A
  • NA N/A
  • P/E Ratio
  • MRKR N/A
  • NA N/A
  • Revenue Growth
  • MRKR N/A
  • NA N/A
  • 52 Week Low
  • MRKR $2.44
  • NA $2.75
  • 52 Week High
  • MRKR $6.16
  • NA $47.50
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 46.47
  • NA 50.73
  • Support Level
  • MRKR $3.52
  • NA $2.77
  • Resistance Level
  • MRKR $3.90
  • NA $9.68
  • Average True Range (ATR)
  • MRKR 0.40
  • NA 1.30
  • MACD
  • MRKR -0.08
  • NA 0.01
  • Stochastic Oscillator
  • MRKR 0.00
  • NA 41.97

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

About NA Nano Labs Ltd

Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.

Share on Social Networks: